Home › Stock analysis › PFE
Pfizer (PFE) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
PFE rises 0.8% to $29.44, a 52-week high. Closed at $29.44, +0.79% vs the prior close of $29.21. Day range $29.42–$29.88, opened at $29.57.
Last close$29.44+0.79%
Day range29.42–29.88
Open29.57
Volume32.87M
52-week range23.62–29.88
Avg volume (20d)32.92M
PFE daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — PFE rises 0.8% to $29.44, a 52-week high
- Closed at $29.44, +0.79% vs the prior close of $29.21. Day range $29.42–$29.88, opened at $29.57.
- Volume was 32.87M shares, 1.0x its 50-day average of 34.04M.
- Price is +5.5% vs its 50-day average ($27.90) and +10.9% vs its 200-day average ($26.54).
- 52-week range $23.62–$29.88; today's close sits at 93% of that range, 1.5% below the 52-week high.
Oct 14, 2026 — PFE rises 3.0% to $29.21, a 52-week high
- Closed at $29.21, +2.96% vs the prior close of $28.37. Day range $28.55–$29.49, opened at $28.60.
- Volume was 39.37M shares, 1.1x its 50-day average of 34.50M.
- Price is +5.0% vs its 50-day average ($27.83) and +10.1% vs its 200-day average ($26.52).
- 52-week range $23.62–$29.49; today's close sits at 95% of that range, 0.9% below the 52-week high.
Oct 13, 2026 — PFE ends flat (-0.1%) to $28.37
- Closed at $28.37, -0.11% vs the prior close of $28.40. Day range $28.13–$28.61, opened at $28.61.
- Volume was 26.84M shares, 0.8x its 50-day average of 34.77M.
- Price is +2.2% vs its 50-day average ($27.75) and +7.1% vs its 200-day average ($26.50).
- 52-week range $23.62–$29.21; today's close sits at 85% of that range, 2.9% below the 52-week high.
Oct 12, 2026 — PFE rises 0.4% to $28.40
- Closed at $28.40, +0.42% vs the prior close of $28.28. Day range $28.28–$28.50, opened at $28.42.
- Volume was 18.56M shares, 0.5x its 50-day average of 35.30M — lighter than usual.
- Price is +2.6% vs its 50-day average ($27.69) and +7.2% vs its 200-day average ($26.48).
- 52-week range $23.62–$29.21; today's close sits at 86% of that range, 2.8% below the 52-week high.
Oct 9, 2026 — PFE rises 1.7% to $28.28
- Closed at $28.28, +1.65% vs the prior close of $27.82. Day range $27.59–$28.29, opened at $27.61.
- Volume was 23.20M shares, 0.6x its 50-day average of 35.74M.
- Price is +2.4% vs its 50-day average ($27.62) and +6.9% vs its 200-day average ($26.46).
- 52-week range $23.62–$29.21; today's close sits at 83% of that range, 3.2% below the 52-week high.
Oct 8, 2026 — PFE dips 0.6% to $27.82
- Closed at $27.82, -0.64% vs the prior close of $28.00. Day range $27.48–$28.00, opened at $27.90.
- Volume was 44.43M shares, 1.3x its 50-day average of 35.46M.
- Price is +1.0% vs its 50-day average ($27.55) and +5.2% vs its 200-day average ($26.45).
- 52-week range $23.62–$29.21; today's close sits at 75% of that range, 4.8% below the 52-week high.
Oct 7, 2026 — PFE rises 1.8% to $28.00
- Closed at $28.00, +1.82% vs the prior close of $27.50. Day range $27.55–$28.17, opened at $27.62.
- Volume was 31.23M shares, 0.9x its 50-day average of 35.83M.
- Price is +1.8% vs its 50-day average ($27.50) and +5.9% vs its 200-day average ($26.44).
- 52-week range $23.62–$29.21; today's close sits at 78% of that range, 4.1% below the 52-week high.
Oct 6, 2026 — PFE rises 0.3% to $27.50
- Closed at $27.50, +0.33% vs the prior close of $27.41. Day range $27.20–$27.71, opened at $27.48.
- Volume was 24.07M shares, 0.7x its 50-day average of 36.12M.
- Price is +0.2% vs its 50-day average ($27.44) and +4.1% vs its 200-day average ($26.42).
- 52-week range $23.62–$29.21; today's close sits at 69% of that range, 5.9% below the 52-week high.
Oct 5, 2026 — PFE dips 1.4% to $27.41, a 1-month low, 5 down days in a row
- Closed at $27.41, -1.40% vs the prior close of $27.80. Day range $27.12–$27.72, opened at $27.65.
- Volume was 33.01M shares, 0.9x its 50-day average of 36.04M.
- Price is +0.1% vs its 50-day average ($27.39) and +3.8% vs its 200-day average ($26.41).
- 52-week range $23.62–$29.21; today's close sits at 68% of that range, 6.2% below the 52-week high.
- That makes 5 straight losses.
Oct 2, 2026 — PFE dips 1.1% to $27.80, 4 down days in a row
- Closed at $27.80, -1.14% vs the prior close of $28.12. Day range $27.44–$28.16, opened at $28.15.
- Volume was 35.01M shares, 1.0x its 50-day average of 35.95M.
- Price is +1.7% vs its 50-day average ($27.33) and +5.3% vs its 200-day average ($26.40).
- 52-week range $23.62–$29.21; today's close sits at 75% of that range, 4.8% below the 52-week high.
- That makes 4 straight losses.
Things to know before you trade PFE
- Last results release: Aug 4, 2026 (8-K Item 2.02). Previous ones: May 5, 2026, Feb 3, 2026, Nov 4, 2025. Based on that rhythm, the next report is likely around Nov 3, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 0.86% (largest 3.0%). That is a relatively calm stock.
- Liquidity: about 32.92M shares (≈$969.07M) trade per day on average.
- 52-week position: $29.44 vs a range of $23.62–$29.88 (93% of the range).
- Dividends: last ex-dividend date Jul 24, 2026 ($0.43/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 3 open-market buys, 2 sales; latest: Albert Bourla bought 38,000 shares on Aug 12, 2026.
- Latest filings: 10-Q Aug 4, 2026; 8-K Aug 4, 2026; 8-K Jun 18, 2026.
- Share count: 5.70B shares outstanding (Jul 29, 2026), +0.2% vs a year earlier.
- Listing: NYSE · industry: Pharmaceutical Preparations.
PFE market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 29.57 | 29.88 | 29.42 | 29.44 | 32.87M |
| Oct 14, 2026 | 28.60 | 29.49 | 28.55 | 29.21 | 39.37M |
| Oct 13, 2026 | 28.61 | 28.61 | 28.13 | 28.37 | 26.84M |
| Oct 12, 2026 | 28.42 | 28.50 | 28.28 | 28.40 | 18.56M |
| Oct 9, 2026 | 27.61 | 28.29 | 27.59 | 28.28 | 23.20M |
| Oct 8, 2026 | 27.90 | 28.00 | 27.48 | 27.82 | 44.43M |
| Oct 7, 2026 | 27.62 | 28.17 | 27.55 | 28.00 | 31.23M |
| Oct 6, 2026 | 27.48 | 27.71 | 27.20 | 27.50 | 24.07M |
| Oct 5, 2026 | 27.65 | 27.72 | 27.12 | 27.41 | 33.01M |
| Oct 2, 2026 | 28.15 | 28.16 | 27.44 | 27.80 | 35.01M |
| Oct 1, 2026 | 28.45 | 28.59 | 28.08 | 28.12 | 30.49M |
| Sep 30, 2026 | 28.79 | 28.95 | 28.52 | 28.52 | 33.63M |
| Sep 29, 2026 | 28.60 | 28.76 | 28.26 | 28.72 | 33.30M |
| Sep 28, 2026 | 28.62 | 28.87 | 28.39 | 28.72 | 24.95M |
| Sep 25, 2026 | 28.45 | 28.69 | 28.17 | 28.67 | 27.76M |
| Sep 24, 2026 | 28.20 | 28.85 | 28.20 | 28.41 | 34.77M |
| Sep 23, 2026 | 27.96 | 28.23 | 27.84 | 28.18 | 33.81M |
| Sep 22, 2026 | 27.74 | 28.00 | 27.49 | 27.93 | 26.66M |
| Sep 21, 2026 | 27.65 | 27.92 | 27.53 | 27.74 | 28.77M |
| Sep 18, 2026 | 27.64 | 27.66 | 27.34 | 27.66 | 75.59M |
About Pfizer
Pfizer (PFE) is listed on the NYSE and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in NEW YORK, NY. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 78003.
PFE board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Ronald E Blaylock | Director | Aug 5, 2026 |
| Albert Bourla | Chairman & CEO | Sep 16, 2026 |
| Mortimer J Buckley | Director | Sep 29, 2026 |
| Susan Desmond-Hellmann | Director | Apr 27, 2026 |
| Joseph Echevarria | Director | Sep 29, 2026 |
| Scott Gottlieb | Director | Apr 27, 2026 |
| Dan R. Littman | Director | Apr 27, 2026 |
| Shantanu Narayen | Director | Sep 29, 2026 |
| Johnson Suzanne M Nora | Director | Apr 27, 2026 |
| James Quincey | Director | Sep 29, 2026 |
| James C Smith | Director | Sep 29, 2026 |
| Cyrus Taraporevala | Director | Sep 29, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Christoffel Boshoff | President, R&D | Mar 5, 2026 |
| Albert Bourla | Chairman & CEO | Sep 16, 2026 |
| Andrew Baum | Executive Vice President | Mar 5, 2026 |
| Jennifer B. Damico | SVP & Controller | Aug 6, 2026 |
| David M Denton | Chief Financial Officer & EVP | Mar 5, 2026 |
| Lidia Fonseca | Executive Vice President | Mar 5, 2026 |
| Cecile Guegan | Executive Vice President | Aug 28, 2026 |
| Dennis P Hancock | Executive Vice President | Apr 27, 2026 |
| Douglas M Lankler | Executive Vice President | Mar 5, 2026 |
| Aamir Malik | Executive Vice President | Mar 5, 2026 |
| Michael Mcdermott | Executive Vice President | Mar 5, 2026 |
| Payal Sahni | Executive Vice President | Mar 5, 2026 |
| Germay Alexandre De | Executive Vice President | Mar 5, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 12, 2026 | Albert Bourla | Buy | 38,000 | $26.34 |
| Aug 5, 2026 | Jennifer B. Damico | Sale | 3,278 | $25.40 |
| Aug 5, 2026 | Mortimer J Buckley | Buy | 37,632 | $25.52 |
| Aug 5, 2026 | Ronald E Blaylock | Buy | 39,231 | $25.46 |
| Jun 9, 2026 | Jennifer B. Damico | Sale | 2,000 | $25.70 |
PFE financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $7.77B | 1.36 | $11.70B |
| Dec 31, 2024 | — | $8.03B | 1.41 | $12.74B |
| Dec 31, 2023 | $50.91B | $2.12B | 0.37 | $8.70B |
| Dec 31, 2022 | $91.79B | $31.37B | 5.47 | $29.27B |
| Dec 31, 2021 | $73.64B | $21.98B | 3.85 | $32.58B |
Latest balance sheet: total assets $201.13B, total liabilities $115.64B, cash $976.00M (as of Jun 28, 2026).
PFE earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 4, 2026 | 8-K Item 2.02 (results) | $25.41 |
| May 5, 2026 | 8-K Item 2.02 (results) | $26.45 |
| Feb 3, 2026 | 8-K Item 2.02 (results) | $25.77 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $24.30 |
| Aug 5, 2025 | 8-K Item 2.02 (results) | $24.75 |
| Apr 29, 2025 | 8-K Item 2.02 (results) | $23.79 |
| Feb 4, 2025 | 8-K Item 2.02 (results) | $25.87 |
| Oct 29, 2024 | 8-K Item 2.02 (results) | $28.46 |
| Jul 30, 2024 | 8-K Item 2.02 (results) | — |
| May 1, 2024 | 8-K Item 2.02 (results) | — |
| Jan 30, 2024 | 8-K Item 2.02 (results) | — |
| Dec 14, 2023 | 8-K Item 2.02 (results) | — |
More on PFE
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.